RetractedArticleOncology letters2014

Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer.

Ying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.